Spanish-language support for Latino youth using an automated insulin pump for type 1 diabetes
Tests Spanish-language support for Latino youth with type 1 diabetes using an insulin pump.
Plain-language title generated from the registry record
Registry title: Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
Key facts
- Where
- Aurora, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 20 years old?
Source: NCT07720388, who can take part
Where in United States
- Barbara Davis CenterAurora, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Colorado, Denver
- Trial code
- NCT07720388
- Record updated
- 30 October 2026
- Original description
This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system.Read full original descriptionShow less
Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system.
The main question it aims to answer is:
Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes?
Participants will:
* Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members
Inclusion: Age 10 - 20 years old; Diagnosis of type 1 diabetes; Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record); Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system; Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study.
Exclusion: Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation; Current use of any Medtronic technology; More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment; Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy; Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study.